Clinical trial And NotChristopher G. Goetz

List of bibliographic references

Number of relevant bibliographic references: 6.

Ident.	Authors (with country if any)	Title
000116	Christina Meyer [Allemagne] ; Bernhard Landwehrmeyer [Allemagne] ; Carsten Schwenke [Allemagne] ; Adam Doble [France] ; Michael Orth [Allemagne] ; Albert C. Ludolph [Allemagne]	Rate of Change in Early Huntington's Disease: a Clinicometric Analysis
000219	Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge V. Van De Witte [Pays-Bas] ; Guus Van Scharrenburg [Pays-Bas]	Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease
000322	Robert A. Hauser [États-Unis] ; Laurence Salin [France] ; Nolwenn Juhel [France] ; Victor L. Konyago [États-Unis]	Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease
000463	Christine Brefel-Courbon [France] ; Karine Desboeuf [France] ; Claire Thalamas [France] ; Monique Galitzky [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]	Clinical and economic analysis of spa therapy in Parkinson's disease
000499	Anne-Catherine Bachoud-Levi [France] ; Philippe Hantraye [France] ; Marc Peschanski [France]	Fetal neural grafts for Huntington's disease: A prospective view
000569	Rascol [France] ; Kasia Sieradzan [Royaume-Uni] ; Hélène Peyro-Saint-Paul [France] ; Claire Thalamas [France] ; Christine Brefel-Courbon [France] ; Jean Michel Senard [France] ; Philippe Ladure [France] ; Jean Louis Montastruc [France] ; Andrew Lees (neurologue) [Royaume-Uni]	Efaroxan, an alpha‐2 antagonist, in the treatment of progressive supranuclear palsy

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024